The Financial Times newspaper is reporting that Novartis AG (NYSE:NVS) is looking at acquisitions as its Swiss-denominated share price rises relative to a weakening American dollar and cash flow is strong.

Paying down debt from the $50 billion acquisition of U.S. eye-care company Alcon, in which it bought its 77 percent stake from Nestle, will make new buys possible, the company’s chairman, Joe Jimenez, told the newspaper.

The drug firm may, however, be happy to let things stand as they are, the newspaper wrote.

“Nestlé owned 77 percent and the company was run very successfully for many years, so we have not ruled that out,” the newspaper quoted Jimenez as saying.

Get the latest news alerts: Follow LTW at Twitter.